Cancer Causes & Control最新文献

{"title":"Determinants of breast screening participation using small-area data in South Australia: gaining past and future insights from geospatial evidence.","authors":"Ming Li, Deborah van Gaans, Muktar Ahmed, Anh-Minh Nguyen, Michelle Reintals, Andrew Holmes, David Roder","doi":"10.1007/s10552-025-02009-z","DOIUrl":"https://doi.org/10.1007/s10552-025-02009-z","url":null,"abstract":"<p><strong>Purpose: </strong>To profile breast screening participation at small-area (SA2) level in South Australia (SA) and capture local variations in socio-economic factors, access to healthcare, and cultural influences screening behaviors in ways that larger administrative units might overlook.</p><p><strong>Methods: </strong>SA2 demographic (2016 Census) and breast screening data in SA (2014-2015) were linked and analyzed. The dependent variable, biennial screening participation (ages 50-74 years), was classified as \"low\" if below the SA-wide biennial participation rate of 58%. Independent variables included SA2-level sociodemographic factors (e.g., socio-economic status, residential remoteness, country of birth) derived from Census data. Stepwise multivariable logistic regression was used to estimate the adjusted odds ratios (aORs) for low screening participation associated with SA2 demographic characteristics.</p><p><strong>Results: </strong>BreastScreen SA participation for the 164 SA2 areas was 50.6%, ranging from 41.1% for ages 55-59 to 67.8% for ages 60-64. Indicators of low participation included disadvantaged socio-economic quintile (aOR increasing to 17.00, 95% CI 9.84-29.36 for quintiles 3-5 compared with the least disadvantaged quintile 1), non-metropolitan residence (aOR 4.94, 95% CI 2.30-10.60), and mortgage/rental stress in low-income households (aOR increasing to 6.59, 95% CI 3.34-13.00 for the third compared with first stress tertile). Areas providing more unpaid care support for disabled/aged people had reduced odds of low screening participation (aOR 0.41, 95% CI 0.24-0.70). Characteristics indicating low odds of low screening included a higher proportion of Australian born (tertile 2, aOR 0.52, 95% CI 0.30-0.88, and tertile 3, aOR 0.27, 95% CI 0.11-0.67).</p><p><strong>Conclusion: </strong>Further model that aims to improve breast screening participation need to be explored at both individual and SA2 levels. Potential cultural and linguistically diverse (CALD), Indigenous, and socio-economic indicators could be drawn from the newly available ABS-managed PLIDA platform. More contemporary SA2 and screening data should also be used for prospective evaluation.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Temporal trends of the disease burden of renal cell carcinoma from 1992 to 2019 in the US: a population-based analysis.","authors":"Ruyan Chen, Tian Tang, Jianglong Han, Si Li, Wenmin Liu, Haiyu Deng, Tingting Jian, Zhenming Fu","doi":"10.1007/s10552-025-02007-1","DOIUrl":"https://doi.org/10.1007/s10552-025-02007-1","url":null,"abstract":"<p><strong>Purpose: </strong>Significant advances in the management, in particular the treatment, of renal cell carcinoma (RCC) has have been made over the years. However, it is not clear whether these advances reduce the disease burden of RCC at the population level.</p><p><strong>Methods: </strong>Using data from the Surveillance, Epidemiology, and End Results database, we estimated the temporal trends of RCC incidence, incidence-based mortality (IBM), and survival rates in the United States (US) from 1992 to 2019.</p><p><strong>Results: </strong>From 2008 to 2019, the incidence increased slowly at 1.1% annually (95% CI: 0.6% to 1.5%). The overall IBM rate of RCC increased by 6.8% per year (95% CI: - 1.1% to 15.3%) between 1994 and 1997, plateaued between 1997 and 2015, and then decreased nonsignificantly after 2015. During the study period, the overall Five year survival rate of RCC continuously increased from 53.69 in 1992 to 72.90% in 2014, with the best improvement observed for RCC patients with distant disease. However, we projected that, given the current trends, the incidence of RCC in the US will continue to increase from 6.92 per 100,000 in 2015-2019 to 9.59 per 100,000 in 2040-2044.</p><p><strong>Conclusion: </strong>Over the years, the mortality of RCC has been decreased reducing at the US population level mainly because the considerably significantly improved survival of RCC patients at all stages through the advances in treatment. However, the overall incidence of RCC is continuously increasing, indicating that more effective preventive strategies should be developed to reduce the disease burden of RCC.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143965571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Building climate resilience and mitigating the impact of climate change on cancer care: strategies and solutions for low and middle income countries.","authors":"Monica Malik, Roselle B De Guzman","doi":"10.1007/s10552-025-02004-4","DOIUrl":"https://doi.org/10.1007/s10552-025-02004-4","url":null,"abstract":"<p><p>Climate change poses an enormous threat to human health. It increases exposure to risk factors related to cancer while simultaneously threatening effective cancer care in the face of overstrained resources and natural hazards. Low and middle income countries (LMICs) are disproportionately affected by the effects of climate change which further limits their ability to respond effectively to this growing threat. Measures to build resilience and mitigate the impact warrant multi-sectoral local and global collaborations. Mitigation strategies positively impact cancer control by reducing exposure to risk factors. The current pace of climate change and the rising rates of cancer incidence in LMICs calls for urgent, effective, evidence-based global efforts toward protecting the health and wellbeing of our planet. This paper discusses strategies to build climate resilience in healthcare and measures to mitigate the emissions of oncology care in LMICs.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.","authors":"Donatus U Ekwueme, Kelly A Reagan, Szu-Yu Kao, Sabitha Dasari, Kristy M Kenney, Manxia Wu, Trevor D Thompson, Jacqueline W Miller","doi":"10.1007/s10552-025-02006-2","DOIUrl":"10.1007/s10552-025-02006-2","url":null,"abstract":"<p><strong>Purpose: </strong>To estimate the number of screenings received, life-years (LYs) saved, and number of screenings per LY saved per woman who participated in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) (Program) compared with those who did not participate (no Program).</p><p><strong>Methods: </strong>We developed a time-to-event simulation model to compare the outcomes of women participating in the Program vs. no Program, categorized by race/ethnicity. Model input parameters included data from the Program's minimum data elements, United States Cancer Statistics, National Health Interview Survey, and published literature. The Program's impact was calculated as the difference in LYs between the Program and no Program using data from 2010 to 2019.</p><p><strong>Results: </strong>Among 1 million women of all races/ethnicities who participated in the NBCCEDP in the last 10 years, 457,152 (standard deviation [SD]: 848) received more screenings than those who did not participate. These participants saved an average of 0.027 LYs per woman screened. In addition, we estimated that about 17 screenings would be required to save an additional 1 LY per woman screened in the Program compared with no Program. Per woman screened by race/ethnicity, non-Hispanic Black women had the highest estimated 0.075 LYs saved, followed by Hispanic women with 0.025 LYs, non-Hispanic White with 0.014 LYs, and non-Hispanic American Indian/Alaska Native and Asian/Pacific Islander had the least health outcome with 0.011 LYs.</p><p><strong>Conclusion: </strong>The reported findings underscore the importance of providing preventive health services to populations that might not otherwise have access to these services.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12246945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceived discrimination, trust in physicians, and their associations with ovarian cancer mortality among women in the African American Cancer Epidemiology Study.","authors":"Lindsay J Collin, Courtney E Johnson, Maxwell Akonde, Mary Kan, Elisa V Bandera, Lauren C Peres, Bo Qin, Michele L Cote, Anthony Alberg, Edward S Peters, Theresa A Hastert, Joellen M Schildkraut","doi":"10.1007/s10552-025-01995-4","DOIUrl":"10.1007/s10552-025-01995-4","url":null,"abstract":"<p><strong>Purpose: </strong>Black women are 30% more likely to die of ovarian cancer than White women. Discrimination may affect cancer health disparities through pathways including socioeconomic disadvantage, chronic stress, and access to care. In this study, we evaluated associations of discrimination and trust in physicians with all-cause mortality among Black women with ovarian cancer.</p><p><strong>Methods: </strong>Using data from the African American Cancer Epidemiology Study (AACES), we included 592 Black ovarian cancer patients who completed an interview. Discrimination and trust in physicians were measured using the Everyday Discrimination, Major Experiences of Discrimination, and Trust in Physicians scales, respectively. We used Cox proportional hazard models to compute multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CIs) associating everyday discrimination, major experiences of discrimination, and trust in physicians with all-cause mortality.</p><p><strong>Results: </strong>Approximately 43% reported experiencing at least one major experience of discrimination, 16% reported high everyday experiences of discrimination, and the median trust in physician score was 35. The association between higher experiences of everyday discrimination was HR = 0.84 (95% CI: 0.63, 1.11), compared with low experiences of everyday discrimination. We observed that more major experiences of discrimination had 1.25-times the mortality rate compared with low experiences of major discrimination (95% CI: 0.84, 2.20). Higher trust in physicians was associated with slightly lower mortality rates (HR = 0.91, 95% CI: 0.74, 1.14).</p><p><strong>Conclusion: </strong>We observed complexities in the relationships of everyday discrimination, major experiences of discrimination, and trust in physicians with mortality among Black women with ovarian cancer. Future work to understand the these relationships is likely warranted.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prediction of suicidal ideation and rumination based on illness perception and social support in cancer patients: A cross-sectional study.","authors":"Mohammadsoroush Agah, Abdol-Azim Seddighi Pashaki, Zahra Taslimi, Behnaz Alafchi, Arya Haddadi, Saeid Yazdi-Ravandi","doi":"10.1007/s10552-025-02005-3","DOIUrl":"https://doi.org/10.1007/s10552-025-02005-3","url":null,"abstract":"<p><strong>Purpose: </strong>According to the World Health Organization, cancer is the second leading cause of death globally after cardiovascular diseases and the third leading cause of death in Iran. It is generally accepted that suicidal thoughts and rumination affect the treatment process of cancer. As the rate of suicide in the first 6 months after cancer diagnosis has been reported seven times compared to the general population. On the other hand, it seems that patients' perception of their disease and social support are predictors of suicidal thoughts and rumination in these patients. In this study, we investigated the impact of disease perception and social support on the level of suicidal thoughts and rumination in cancer patients.</p><p><strong>Methods: </strong>This descriptive-analytical cross-sectional study was conducted on the adult cancer patients of Hamadan city in 2024. A total of 250 patients were selected through convenience sampling. Data were collected using the Beck Scale for Suicidal Ideation (BSSI), the Nolen-Hoeksema and Morrow Rumination Questionnaire, the Brief Illness Perception Questionnaire (BIPQ), and the Social Support Questionnaire (SS-A). Data analysis was performed using Pearson correlation coefficient and regression analysis with the application of SPSS-26 software.</p><p><strong>Results: </strong>The findings indicate that social support (β = - 0.458, p < 0.001 (and disease perception (β = 0.168, p = 0.003) are significant predictors of suicidal thoughts. Additionally, increased disease perception (β = 0.242, p = 0.000) can lead to increased rumination (β = - 0.379, p = 0.000), while social support (β = - 0.379, p = 0.000) plays a protective role in reducing rumination.</p><p><strong>Discussion: </strong>The results of this study show that disease perception and social support can predict suicidal thoughts and rumination in cancer patients. Clinically, the findings emphasize the necessity of considering psychological factors such as disease perception and social support in the treatment process of cancer patients.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A narrative review of sleep and breast cancer: from epidemiology to mechanisms.","authors":"Bao Zhang, Mengsha Tang, Xiude Li","doi":"10.1007/s10552-024-01951-8","DOIUrl":"10.1007/s10552-024-01951-8","url":null,"abstract":"<p><p>Breast cancer is the leading cause of cancer-related death and the most common cancer among women worldwide. It is crucial to identify potentially modifiable risk factors to intervene and prevent breast cancer effectively. Sleep factors have emerged as a potentially novel risk factor for female breast cancer. Current epidemiologic studies suggest a significant impact of sleep factors on breast cancer. Exposure to abnormal sleep duration, poor sleep quality, sleep disorders, sleep medication use, or night shift work can increase the risk of breast cancer by decreasing melatonin secretion, disrupting circadian rhythm, compromising immune function, or altering hormone levels. However, there are still controversies regarding the epidemiologic association, and the underlying mechanisms have yet to be fully elucidated. This paper summarizes the epidemiologic evidence on the associations between sleep factors, including sleep duration, sleep quality, sleep disorders, sleep medication use, sleep habits, and night shift work, and the development of breast cancer. The potential mechanisms underlying these associations were also reviewed.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"457-472"},"PeriodicalIF":2.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.","authors":"Florence K L Tangka, Kristy Kenney, Jacqueline Miller, David H Howard","doi":"10.1007/s10552-024-01947-4","DOIUrl":"10.1007/s10552-024-01947-4","url":null,"abstract":"<p><strong>Purpose: </strong>The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to timely breast and cervical cancer screening and diagnostic services to women who have low incomes and are uninsured or underinsured. Documenting the number of women eligible and the proportion of eligible women who receive NBCCEDP-funded services is important for identifying opportunities to increase screening and diagnostic services among those who would not otherwise have access.</p><p><strong>Methods: </strong>Using the Census Bureau's Small Area Health Insurance Estimates data, we estimated the number of women who met the NBCCEDP eligibility criteria based on age, income, and insurance status. We used these estimates along with the number of women served by the NBCCEDP to calculate the percent of women served by race/ethnicity and state. We calculated the percent of eligible women who are up to date with screening using the 2019 National Health Interview Survey.</p><p><strong>Results: </strong>The NBCCEDP served 15.0% of women ages 40-64 eligible for breast cancer services in 2018-2019 and 5.6% of women ages 21-64 eligible for cervical cancer services in 2018-2020. The NBCCEDP served 13.5% of women ages 40-64 eligible for breast cancer services in 2020-2021 and 5.9% of women ages 21-64 eligible for cervical cancer services in 2019-2021. The percent of women ages 40-64 who received breast cancer services declined by 1.5 percentage points between 2018-2019 and 2020-2021. The percent of women ages 21-64 who received cervical cancer services increased by 0.3 percentage points between 2018-2020 and 2019-2021. The percent of eligible women served varied among states. The state interquartile ranges of the percent of women served were 12.3-27.7% for breast cancer services in 2018-2019 and 3.9-14.7% for cervical cancer services in 2018-2020. Among women eligible for the NBCCEDP, 61.4% are not up to date with breast cancer screening and 40.6% are not up to date with cervical cancer screening.</p><p><strong>Conclusion: </strong>There is wide variation between states in the share of eligible women served for breast and cervical cancer screening services. We found that both the number and the percentage of eligible women who received NBCCEDP breast cancer services declined during a period that overlapped with the COVID-19 pandemic. A large proportion of eligible women did not receive breast or cervical cancer screening.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"531-538"},"PeriodicalIF":2.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142943815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer.","authors":"Alina Vrieling, Linnea T Olsson, Guyon Kleuters, Jake S F Maurits, Katja Aben, J P Michiel Sedelaar, Helena Furberg, Lambertus A L M Kiemeney","doi":"10.1007/s10552-024-01957-2","DOIUrl":"10.1007/s10552-024-01957-2","url":null,"abstract":"<p><strong>Purpose: </strong>Obesity in mid-life is a well-established risk factor for developing renal cell carcinoma (RCC); however, patients with RCC who are obese at the time of diagnosis have more favorable survival outcomes. To get better insight into the obesity paradox and determine the extent to which weight around diagnosis is stable, we examined pre- and post-diagnosis weight changes in patients with localized RCC.</p><p><strong>Methods: </strong>We included 334 patients with localized RCC from the prospective cohort ReLife who self-reported body weight at multiple time points ranging from 2 years before to 2 years after diagnosis. Multivariable linear mixed-effects regression models were used to compare weight at each timepoint to weight at diagnosis for the overall study population, as well as stratified by BMI at diagnosis, tumor stage, and tumor grade.</p><p><strong>Results: </strong>Most patients were classified as overweight (38.3%) or obese (29.6%) at diagnosis. Overall, patients experienced on average 1.45 kg (95% confidence interval (CI) 0.84, 2.06) weight loss in the 2 years before diagnosis. Pre-diagnosis weight loss was higher in patients who were non-obese at diagnosis, and who presented with higher tumor stage and grade. On average, pre-diagnosis weight loss was at least partially regained within two years after diagnosis.</p><p><strong>Conclusion: </strong>Patients who were non-obese and patients with higher stage and grade tumors had higher pre-diagnosis weight loss, which was at least partially regained after treatment. These patterns suggest there are subgroups of patients with localized RCC who experience disease-related weight loss, which could contribute to the obesity paradox.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"497-507"},"PeriodicalIF":2.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating health status and risks among Native Hawaiian and Pacific Islander communities in Hawai'i: a respondent-driven sampling approach.","authors":"Mark L Willingham, Rodney S Teria, Louis Dulana, Grazyna Badowski, Kevin D Cassel","doi":"10.1007/s10552-024-01956-3","DOIUrl":"10.1007/s10552-024-01956-3","url":null,"abstract":"<p><strong>Purpose: </strong>Respondent-driven sampling (RDS) is a sampling method that relies on social networks to recruit hard-to-reach populations, and reduces the bias from non-random selection. This study aimed to assess the efficacy of RDS in collecting health assessment data from underrepresented populations not captured by traditional sampling techniques.</p><p><strong>Methods: </strong>An RDS study was conducted in Hawai'i between 2017 and 2018 of Native Hawaiians, Chuukese, and Marshallese participants. 1006 cases consisting of 352 seeds and 654 recruits were analyzed in conjunction with data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS), filtered to include Native Hawaiian/Other Pacific Islander participants (n = 1564). Missing network size data was imputed by RDSAnalyst and determined by the sample median network size. Weighted samples were compared for differences.</p><p><strong>Results: </strong>Chi-square testing revealed significant differences between the RDS and BRFSS weighted samples across sex, age, education, income, and colon/cervical cancer screening variables. Only BMI group and smoking status exhibited no significant differences. RDS methods recruited participants efficiently within one year.</p><p><strong>Conclusion: </strong>The findings indicate that RDS offers an effective sampling methodology when trying to reach hidden populations and provides more insight into the social networks of underserved communities as the transfer/utilization of health information may be linked to social connectedness.</p>","PeriodicalId":9432,"journal":{"name":"Cancer Causes & Control","volume":" ","pages":"521-530"},"PeriodicalIF":2.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}